Vutrisiran in transthyretin amyloid cardiomyopathy: a structured review of the HELIOS-B trial and its secondary analyses.

Niazai A, Zurmati BM, Shah ST, Hikmat G, Sohaib HU, Zainab HH, Faridzai MJK, Nisar MR

DOI: 10.1186/s12872-026-06113-z
Published: 2026 Jun 10
Container: BMC cardiovascular disorders
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12872-026-06113-z,
  title = {Vutrisiran in transthyretin amyloid cardiomyopathy: a structured review of the HELIOS-B trial and its secondary analyses.},
  author = {Niazai A and Zurmati BM and Shah ST and Hikmat G and Sohaib HU and Zainab HH and Faridzai MJK and Nisar MR},
  year = {2026},
  journal = {BMC cardiovascular disorders},
  doi = {10.1186/s12872-026-06113-z},
  url = {https://doi.org/10.1186/s12872-026-06113-z}
}

RIS

TY  - JOUR
TI  - Vutrisiran in transthyretin amyloid cardiomyopathy: a structured review of the HELIOS-B trial and its secondary analyses.
AU  - Niazai A
AU  - Zurmati BM
AU  - Shah ST
AU  - Hikmat G
AU  - Sohaib HU
AU  - Zainab HH
AU  - Faridzai MJK
AU  - Nisar MR
PY  - 2026
JO  - BMC cardiovascular disorders
DO  - 10.1186/s12872-026-06113-z
UR  - https://doi.org/10.1186/s12872-026-06113-z
ER  -

APA

A, N., BM, Z., ST, S., G, H., HU, S., HH, Z., MJK, F., & MR, N. (2026). Vutrisiran in transthyretin amyloid cardiomyopathy: a structured review of the HELIOS-B trial and its secondary analyses.. BMC cardiovascular disorders. https://doi.org/10.1186/s12872-026-06113-z

Source records

pubmed · retrieved 2026-09-26T23:09:02.633Z